Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Self-controlled levothyroxine dose adjustment in treated hypothyroidism
NL-OMON29339Not yet recruiting
- Sponsor
- Maasstad Ziekenhuis
- Start
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in primary hypothyroidism (PH) comparing Immediate levothyroxine increase first randomization with Placebo first, delayed levothyroxine increase (2 arms). Primary endpoints: Quality of life, Hypothyroidism symptoms and complaints and 4 more. Planned start Jul 2011; status: not yet recruiting.
02
Drugs
levothyroxine sodium
03
Conditions
primary hypothyroidism (PH)
Beyond the preview
Go deeper on NL-OMON29339.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON29339.